SARS-CoV-2 Virus Propagation and Inactivation
Corresponding Organization : The University of Texas Health Science Center at Houston
Variable analysis
- Multiplicity of infection (MOI) of 0.005 for virus propagation in Vero-E6 cells
- Virus titer by plaque titration assay
- Loss of infectivity of β-Propiolactone treated virus in Vero-E6 cells
- Total protein content of concentrated virus
- Vero-E6 cell line used for virus propagation and infectivity testing
- Cell culture conditions (Nunc cell factory system, temperature, incubation time)
- Centrifugation parameters (4000 rpm, 15 min, 4 °C) for virus clarification
- Concentration of β-Propiolactone (0.1%) and incubation time (2 days) for virus inactivation
- Ultrafiltration and ultracentrifugation parameters for virus concentration
- Virus-infected Vero-E6 cells to observe cytopathic effect
- Uninfected Vero-E6 cells as a control for cytopathic effect
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!